Abstract
AbstractOver the last few decades, Europe has seen a rise in applications for “native trait” patents on conventionally bred plants. Based on expert interviews, participant observation, patent statistics and document analysis, this chapter discusses what constitutes the (potential) value of these patents for various stakeholders. Native trait patents are a legacy of biotech plant patents from the 1980s and 1990s but follow different material, legal and economic logics. Unlike GMO patents, it would be wrong to view them as tools with which to extract surplus value from farmers. Neither, however, are they simply a means to capture investment from stock markets. There is no single business model that could explain the rush of companies to apply for patents in conventional plant breeding; therefore, patents must be understood as complex value objects that fulfil different functions for different actors and that often defy their original purpose of stimulating and protecting innovation.
Publisher
Springer International Publishing
Reference48 articles.
1. Acquaah, G. (2012). Principles of Plant Genetics and Breeding (2nd ed.). Hoboken: Wiley.
2. Backhouse, M., Lorenzen, K., Lühmann, M., Puder, J., Rodríguez, F., & Tittor, A. (2017). Bioökonomie-Strategien im Vergleich. Gemeinsamkeiten, Widersprüche und Leerstellen. Working Paper Nr. 1, Bioeconomy & Inequalities, Jena. https://www.bioinequalities.uni-jena.de/sozbemedia/neu/2017-09-28+workingpaper+1.pdf. Accessed 19 Oct 2020.
3. Becker, H. (2011). Pflanzenzüchtung (2nd ed.). Stuttgart: Verlag Eugen Ulmer.
4. Bently, L., & Sherman, B. (2014). Intellectual Property Law (4th ed.). Oxford: Oxford University Press.
5. Bertacchini, E.E. (2008). Coase, Pigou and the Potato: Whither Farmers’ Rights? Ecological Economics, 68(1–2), 183–193.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献